SEARCH SITE

VIRGINIA LAW PORTAL

SEARCHABLE DATABASES

ACROSS SESSIONS

Developed and maintained by the Division of Legislative Automated Systems.

1999 SESSION

  • | print version

HB 2653 Health insurance; coverage for certain ovarian cancer testing.

Introduced by: Jay Katzen | all patrons    ...    notes | add to my profiles

SUMMARY AS INTRODUCED:

Accident and sickness insurance; coverage for certain ovarian cancer testing. Requires health insurers, health maintenance organizations, and corporations providing accident and sickness subscription contracts to provide coverage to (i) any post-menopausal woman or (ii) any woman who is at high risk of ovarian cancer, according to the most recently published guidelines of the American Cancer Society, for one CA 125 test or, when available, one LPA test, in a 12-month period, all in accordance with American Cancer Society guidelines under any such policy, contract or plan delivered, issued for delivery or renewed in this Commonwealth on and after July 1, 1999. “CA 125 test” is defined as the analysis of a blood sample to determine the presence of the tumor marker, CA 125, which may indicate the existence of ovarian cancer cells. “LPA test” means the analysis of a blood sample to detect elevated levels of lysophosphatidic acid (LPA), a substance which stimulates the growth of ovarian cancer cells. Because the LPA test is not yet marketed, this provision would require coverage if the LPA test is available. The requirements of this bill will not apply to (i) short-term travel, accident only, limited or specified disease policies other than cancer policies, (ii) short-term nonrenewable policies of not more than six months’ duration, or (iii) policies of contracts designed for issuance to persons eligible for coverage under Title XVIII of the Social Security Act, known as Medicare, or any other similar coverage under state or federal governmental plans.


FULL TEXT

HISTORY